Abstract
In most mammals, labor is heralded by progesterone withdrawal, which is believed to be related to the activation of multiple pathways leading to parturition. In humans, despite no decrease in placental progesterone production, activation of similar pathways preceding labor suggests the presence of an endogenous antiprogestin, which we reasoned might be cortisol, whose secretion from the fetal adrenal rises markedly at the end of human gestation. We report that in primary cultures of human placenta, cortisol is able to compete with the action of progesterone in the regulation of the corticotropinreleasing hormone (CRH) gene. CRH is a peptide highly expressed in human placenta at the end of gestation, which has been suggested to be involved in regulating the timing of parturition. These findings provide a model for functional progesterone withdrawal at the end of human pregnancy, which may be involved in the initiation of labor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Csapo, A.I. The “see-saw” theory of parturition. Ciba Found. Symp. 47, 159–210 (1977).
Liggins, G.C. Mechanisms of the onset of labor: The New Zealand perspective. Aust. N. Z. J. Obstet. Gynaecol. 34, 338–342 (1994).
Casey, M.L. & MacDonald, P.C. Biomolecular processes in the initiation of parturition: Decidual activation. Clin. Obstet. Gynecol. 31, 533–552 (1988).
Tulchinsky, D., Hobel, C.J., Yeager, E. & Marshall, J.R. Plasma estrone, estradiol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am. J. Obstet. Gynecol. 112, 1095–1100 (1972).
Baulieu, E.E. Contragestion and other clinical applications of RU 486, an anti-progesterone at the receptor. Science 245, 1351–1357 (1989).
Lelaidier, C. et al. Mifepristone for labour induction after previous caesarean section. Br. J. Obstet. Gynaecol. 101, 501–503 (1994).
Westphal, U., Stroupe, S.D. & Cheng, S.L. Progesterone binding to serum proteins. Ann. NY Acad. Sci. 286, 10–28 (1977).
Casey, M.L. & MacDonald, P.C. Human parturition: Distinction between the initiation of parturition and the onset of labor. Semin. Reprod. Endocrinol. 11, 272–284 (1993).
Khan-Dawood, F.S. & Dawood, M.Y. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy. Am. J. Obstet. Gynecol. 150, 501–505 (1984).
Anderson, A.B., Flint, A.P. & Turnbull, A.C. Mechanism of action of glucocorticoids in induction of ovine parturition: Effect on placental steroid metabolism. J. Endocrinol. 66, 61–70 (1975).
Fencl, M.D., Stillman, R.J., Cohen, J. & Tulchinsky, D. Direct evidence of sudden rise in fetal corticoids late in human gestation. Nature 287, 225–226 (1980).
Siiteri, P.K. & MacDonald, P.C. The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy. Steroids 2, 713–730 (1963).
Ryan, K.J. Maintenance of pregnancy and the initiation of labor. in Maternal-Fetal Endocrinology (eds. Tulchinsky, D. & Ryan, K. J.) 297–309 (Saunders, Philadelphia, 1980).
Jahn, G.A., Houbedine, L.-M. & Djiane, J. Antiprogesterone and antiglucocorticoid actions of RU 486 on rabbit mammary explant cultures: Evidence for a persistent inhibitory action of residual progesterone upon the mammary tissue. J. Steroid Biochem. 28, 371–377 (1987).
Nordeen, S.K., Kuhnel, B., Lawler-Heavner, J., Barber, D.A. & Edwards, D.P. A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. Mol. Endocrinol. 3, 1270–1278 (1989).
Vale, W., Spiess, J. & Rivier, C., Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotrophin and beta-endorphin. Science 213, 1394–1397 (1981).
Frim, D., Emanuel, R., Robinson, B. & Majzoub, J.A. Characterization and gestational regulation of corticotrophin releasing hormone messenger RNA in human placenta. J. Clin. Invest. 82, 287–292 (1988).
Goland, R.S., Wardlaw, S.L., Blum, M., Tropper, P.J. & Stark, R.I. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy. Am. J. Obstet. Gynecol. 159, 884–890 (1988).
Robinson, B., Emanuel, R., Frim, D. & Majzoub, J.A. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. USA 88, 5244–5248 (1988).
Jones, S.A., Brooks, A.N. & Challis, J.R. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J. Clin. Endocrinol. Metab. 68, 825–830 (1989).
Sawchenko, P.E. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: Anatomic, peptide, and steroid specificity. J. Neurosci. 7, 1093–1106 (1987).
Speeg, K.V. & Harrison, R.W. The ontogeny of human placental glucocorticoid receptor and inducibility of heat-stable alkaline phosphatase. Endocrinology 104, 1364–1370 (1979).
Kliman, H.J., Nestler, J.E., Sermasi, E., Sanger, J.M. & Strauss, J., Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118, 1567–1582 (1986).
Bloch, K. The biological conversion of cholesterol to pregnanediol. J. Biol. Chem. 157, 661–666 (1945).
Okamoto, E. et al. Immunoreactive corticotropin-releasing hormone, adreno-corticotropin and cortisol in human plasma during pregnancy and delivery and postpartum. Horm. Metab. Res. 21, 566–572 (1989).
von der Ahe, D. et al. Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature 313, 706–709 (1985).
Strahle, U., Boshart, M., Klock, G., Stewart, F. & Schutz, G. Glucocorticoid-and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature 339, 629–632 (1989).
Philibert, C.G. et al. From RU 38486 towards dissociated anti-glucocorticoid and antiprogesterone. Front. Horm. Res. 19, 1–17 (1991).
Ojasoo, T., Dore, J.C., Gilbert, J. & Raynaud, J-P., Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis. J. Med. Chem. 31, 1160–1169 (1989).
Slater, E.P., Cato, A.C., Karin, M., Baxter, J.D. & Beato, M. Progesterone induction of metallothionein-IIA Gene expression. Mol. Endocrinol. 2, 485–491 (1988).
Lippman, M., Huff, K. & Bolan, G. Progesterone and glucocorticoid interactions with receptor in breast cancer cells in long-term tissue culture. Ann. NY Acad. Sci. 286, 101–115 (1977).
Gasparoni, A. et al. Neutrophil chemotaxis in infants delivered by caesarean section. Eur. J. Pediatr. 150, 481–482 (1991).
Liggins, G.C. Endocrinology of parturition. in Fetal Endocrinology (eds. Novy, M.J. & Resko, J.A.) 211–237 (Academic Press, New York, 1981).
Schwarz, B.E. et al. Progesterone binding and metabolism in human fetal membranes. Ann. NY Acad. Sci. 286, 304–312 (1977).
Robinson, E.G., Arbiser, J.L., Emanuel, R. & Majzoub, J.A. Species-specific placental corticotropin-releasing hormone messenger RNA and peptide expression. Mol. Cell. Endocrinol. 62, 337–341 (1989).
Stalla, G.K. et al. Human corticotropin-releasing hormone during pregnancy. Gynecol. Endocrinol. 3, 1–10 (1989).
Berghorn, K.A., Albrecht, E.D. & Pepe, G.J. Responsivity of the baboon fetal pituitary to corticotropin-releasing hormone in utero at midgestation. J. Clin. Endocrinol. Metab. 129, 1424–1428 (1991).
Siiteri, P.K. & Seron-Ferre, M. Some new thoughts on the feto-placental unit and parturition in primates. in Fetal Endocrinology, (eds. M.J. Novy, M.J. & Resko, J.A.) 1–34 (Academic Press, New York, 1981).
Emanuel, R.L. et al. Corticotropin releasing hormone levels in human plasma and amniotic fluid during gestation. Clin. Endocrinol. 40, 257–262 (1994).
McLean, M. et al. A placental clock controlling the length of human pregnancy. Nature Med. 1, 460–463 (1995).
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).
Cidlowski, J.A., Bellingham, D.L., Powell-Oliver, F.E., Lubahn, D.B. & Sar, M. Novel antipeptide antibodies to the human glucocorticoid receptor: Recognition of multiple receptor forms in vitro and distinct localization of cytoplasmic and nuclear receptors. Mol. Endocrinol. 4, 1427–1437 (1990).
Press, M.F., Udove, J.A. & Greene, G.L. Progesterone receptor distribution in the human endometrium. Am. J. Pathol. 131, 112–124 (1988).
Majzoub, J.A. & Adler, G. Assays for Corticotropin releasing hormone and vasopressin messenger RNAs. Methods Neurosci. 52, 1160–1167 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karalis, K., Goodwin, G. & Majzoub, J. Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat Med 2, 556–560 (1996). https://doi.org/10.1038/nm0596-556
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0596-556
This article is cited by
-
Fetal Exosomal Platelet-activating Factor Triggers Functional Progesterone Withdrawal in Human Placenta
Reproductive Sciences (2021)
-
Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women
Scientific Reports (2020)
-
Glucocorticoid receptor gene polymorphisms and disease activity during pregnancy and the postpartum period in rheumatoid arthritis
Arthritis Research & Therapy (2012)